SGS to increase E&L identification capabilities at Fairfield lab

Published: 26-Jan-2017

Bio/pharmaceutical, analytical and bioanalytical contract solutions provider SGS will increase services in extractables and leachables

It will be testing within the pharmaceutical and related industries at its laboratory in Fairfield, New Jersey. It is a North American Center of Excellence for extractables and leachables (E&L).

Two state-of-the-art instruments have been installed and validated and hiring is underway for additional analysts.

The new instruments are a Liquid chromatography tandem-mass spectrometry (LC-MS/MS) and Gas chromatography mass spectrometry (GC-MS) with head-space capability.

They are both high resolution and high throughput systems, for rapid identification of trace unknown extractable compounds.

The laboratory currently offers testing facilities for a wide range of E&L applications, including final pharmaceutical packaging, single-use systems and medical devices.

Kelly Bertrand is General Manager of SGS’s Fairfield facility. “The additional capabilities we have now at Fairfield allow us to overcome greater analytical challenges for our existing clients, and ensure we can remain competitive and have the capacity to attract new customers,” she said.

SGS is an inspection, verification, testing and certification company. It has 21 laboratories offering contract analytical and bioanalytical services in North America, Europe, and Asia.

It provides Phase I-IV clinical trial management, data management and statistics services, pharmacokinetic/pharmacodynamic (PK/PD) modeling and simulation, pharmacovigilance and regulatory consultancy.

You may also like